x
Visit our new Mobile Website next time you access NetDania with your mobile device

CYTOMX THERAPEUTICS INC. - COMMON STOCK

1.9800
10-19:59:59 GMT
-0.0600
-2.9412%
ISIN:N/A

Figures - CYTOMX THERAPEUTICS INC. - COMMON STOCK

Open
2.0300
Close
2.0400
Year Change
27.7420
Year % Change
+27.7420%
52 Week High
5.8500
52 Week Low
1.0400
Volume
12154821
Inc. Vol
37062

News - CYTOMX THERAPEUTICS INC. - COMMON STOCK

13-06:49 GMT
FC Barcelona Vs. Real Sociedad Preview: Xavi Goes All In With Lineup
Source: Forbes World, Symbol: CYTOMX THERAPEUTICS INC. - COMMON STOCK
13-06:49 GMT
Adesso SE Slips To Q1 Loss, Sales Revenues Climb; Backs FY24 Outlook
Source: NASDAQ US Markets, Symbol: CYTOMX THERAPEUTICS INC. - COMMON STOCK
13-06:49 GMT
Salzgitter Q1 Profit Declines; External Sales Down 10.2%
Source: NASDAQ US Markets, Symbol: CYTOMX THERAPEUTICS INC. - COMMON STOCK
13-06:23 GMT
Regeneron : Dupixent SBLA Accepted For FDA Priority Review For Adolescent Chronic Rhinosinusitis
Source: NASDAQ US Markets, Symbol: CYTOMX THERAPEUTICS INC. - COMMON STOCK
13-06:23 GMT
Sanofi To Invest Over EUR 1 Bln Further For Biomanufacturing In France
Source: NASDAQ US Markets, Symbol: CYTOMX THERAPEUTICS INC. - COMMON STOCK
13-06:23 GMT
The Ultimate Growth Stock to Buy With $1,000 Right Now
Source: NASDAQ US Markets, Symbol: CYTOMX THERAPEUTICS INC. - COMMON STOCK
13-06:23 GMT
Robinhood Just Got Hit With a Wells Notice. What Is That, and Why Could It Be Huge News for the Stock?
Source: NASDAQ US Markets, Symbol: CYTOMX THERAPEUTICS INC. - COMMON STOCK
13-06:18 GMT
Billionaire Razon’s ICTSI To Build $800 Million Cargo Terminal Outside Manila
Source: Forbes World, Symbol: CYTOMX THERAPEUTICS INC. - COMMON STOCK
13-05:55 GMT
Why AI Won’t Take Over The World Anytime Soon
Source: Forbes World, Symbol: CYTOMX THERAPEUTICS INC. - COMMON STOCK
13-05:55 GMT
Is Starbucks Stock a Buy After Its Massive Drop?
Source: NASDAQ US Markets, Symbol: CYTOMX THERAPEUTICS INC. - COMMON STOCK
13-05:55 GMT
1 Dividend Stock Down 47%: Should You Buy It Hand Over Fist Right Now?
Source: NASDAQ US Markets, Symbol: CYTOMX THERAPEUTICS INC. - COMMON STOCK
13-05:55 GMT
European Shares Poised For Mixed Open
Source: NASDAQ US Markets, Symbol: CYTOMX THERAPEUTICS INC. - COMMON STOCK
13-05:29 GMT
K+S Q1 Earnings, Revenues Down; Backs FY24 Outlook For Weak EBITDA
Source: NASDAQ US Markets, Symbol: CYTOMX THERAPEUTICS INC. - COMMON STOCK
13-05:12 GMT
IBM Releases Granite AI Models To Open-Source Community
Source: Forbes World, Symbol: CYTOMX THERAPEUTICS INC. - COMMON STOCK
13-05:01 GMT
Sensex, Nifty Tumble On Weak Global Cues
Source: NASDAQ US Markets, Symbol: CYTOMX THERAPEUTICS INC. - COMMON STOCK
13-04:37 GMT
What's Next For Electronic Arts Stock After A Q4 Miss And Soft FY25 Guidance?
Source: NASDAQ Stocks, Symbol: CYTOMX THERAPEUTICS INC. - COMMON STOCK
13-04:37 GMT
UBS Stock Is Up 4.5% Since The Q1 Results, What To Expect Next?
Source: NASDAQ Stocks, Symbol: CYTOMX THERAPEUTICS INC. - COMMON STOCK
13-04:37 GMT
With Streaming Business Turning Around, Is Disney Stock Attractive At $105?
Source: NASDAQ Stocks, Symbol: CYTOMX THERAPEUTICS INC. - COMMON STOCK
13-04:37 GMT
Why We Love ‘Set It and Forget It’ Trades
Source: NASDAQ Stocks, Symbol: CYTOMX THERAPEUTICS INC. - COMMON STOCK
13-04:22 GMT
SEC Track And Field Championships Produce World Leading Times And Olympic Performances
Source: Forbes World, Symbol: CYTOMX THERAPEUTICS INC. - COMMON STOCK
Five Star Chart – Build your favorite menu, 100+ studies, for mobile and desktop
Find a Top Broker
Global
Forex
39532.46
51.12
0.13%
5230.82
11.68
0.22%
18209.71
57.82
0.32%
61722.00
260
0.42%
18819.76
17.8
0.09%
38124.89
-94.78
-0.25%
3146.74
-7.81
-0.25%
8435.98
9.67
0.11%
19089.21
138.33
0.73%
7750.17
4.63
0.06%
22013.20
-42
-0.19%
2348.40
-11.22
-0.48%
82.62
-0.058
-0.07%
1.07712
0.00052
0.05%
155.868
0.178
0.11%
1.25250
0.00053
0.04%
0.65970
-0.00011
-0.02%
1.36824
0.0017
0.12%
167.89200
0.234
0.14%
0.85995
0.00079
0.09%
195.22500
0.339
0.17%
0.90671
0.0009
0.10%
0.97664
0.00105
0.11%
0.60076
-0.00108
-0.18%
105.30500
-0.001
0.00%
Top Gainers
Name
Last
+/-
%
0.02
0.01
129.35%
2.58
1.38
115.00%
8.88
4.41
98.66%
0.01
0.00
63.89%
0.09
0.03
52.08%
0.02
0.01
50.00%
0.03
0.01
47.18%
17.44
5.25
43.07%
5.29
1.48
38.84%
0.11
0.03
36.25%
Top Losers
Name
Last
+/-
%
3.31
-11.36
-77.44%
0.01
-0.01
-51.20%
0.20
-0.15
-42.86%
2.36
-1.48
-38.54%
0.04
-0.03
-37.20%
0.04
-0.02
-36.24%
0.25
-0.14
-35.09%
0.58
-0.27
-32.04%
0.25
-0.11
-30.56%
0.00
0.00
-29.79%
NetDania does not guarantee the accuracy of data contained on this website, nor do we guarantee that data is real-time. Data on this website may be provided from OTC market sources and market makers, and not necessarily from exchanges. The provided price data is indicative and may not be appropriate for trading or decision making purposes. NetDania does not assume any responsibility for any losses incurred from the use of the provided data.
NetDania does not endorse or promote any broker or financial service. NetDania is a pure technology provider offering its software with broker integration. Any user of NetDania software must be an existing client of one of our supported brokers. NetDania showcases NetDania technology for the purpose of demonstrating it towards brokers and other institutions looking to white label the technology on a software subscription contract. No financial services are offered, promoted or recommended. NetDania is compensated as a technology provider by its institutional clients including its integrated brokers. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation affecting it.

Persons or entities including approved brokers not belonging to the NetDania Group may advertise on the NetDania and its Group’s websites, through links, banners or otherwise. We have not taken any steps to verify the accuracy, quality or reliability of any products, information or services provided by third parties that have links on our website. We accordingly provide no warranties with regard to and disclaim responsibility for any such products, information or services and exclude all liability in this regard to the fullest extent permitted by relevant laws and regulations. If a user of the NetDania Group’s websites decides to act upon any such advertising, such user does so entirely at its own risk.

NetDania’s website may be accessed worldwide. The Information provided on its website is however only intended for use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. None of the offerings services referred to on this website are available to recipients residing in countries where the provision of such offerings would constitute a violation of mandatory applicable legislation or regulations. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation.

HIGH RISK INVESTMENT WARNING:
End-users of the NetDania software that make use of the trading integration features as direct clients of integrated brokers, should be aware of the level of risk carried by trading in financial markets. Trading foreign exchange and or other financial instruments on margin carries a high level of risk, and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to invest you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or more of your initial investment, and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading, and seek advice from your broker and or an independent financial advisor if you have any doubts. Anyone opening a live trading account needs to adhere to the laws of their local country as such laws may differ from country to country.
NetDania expressly disclaims any liability for any lost principal or profits which without limitation may arise directly or indirectly from the use of or reliance on information on our website or the use of our software with broker integration.
Copyright © 1998 -2024 NetDania Creations ApS, Holmens Kanal 7, 1060 Copenhagen K, Denmark, +4536988200, Contact NetDania by email, CVR-nr.27976670 Terms And Conditions and Privacy Policy